Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Substance Misuse To Psychosis for Stimulants (SToP-S)
NCT03485417Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Jun 2019
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole, paliperidone in stimulant-induced psychotic disorder (SIPD), sponsored by The University of Hong Kong. Started Jun 2019; status: completed.
02
Drugs
aripiprazolepaliperidone
03
Conditions
stimulant-induced psychotic disorder (SIPD)
Beyond the preview
Go deeper on NCT03485417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485417.